WO2000066105A3 - Treatment of epilepsy with imino sugars - Google Patents
Treatment of epilepsy with imino sugars Download PDFInfo
- Publication number
- WO2000066105A3 WO2000066105A3 PCT/US2000/011584 US0011584W WO0066105A3 WO 2000066105 A3 WO2000066105 A3 WO 2000066105A3 US 0011584 W US0011584 W US 0011584W WO 0066105 A3 WO0066105 A3 WO 0066105A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- epilepsy
- treatment
- imino sugars
- imino
- sugars
- Prior art date
Links
- 206010015037 epilepsy Diseases 0.000 title abstract 2
- -1 imino sugars Chemical class 0.000 title abstract 2
- 235000000346 sugar Nutrition 0.000 title abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Saccharide Compounds (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13212599P | 1999-04-30 | 1999-04-30 | |
US60/132,125 | 1999-04-30 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000066105A2 WO2000066105A2 (en) | 2000-11-09 |
WO2000066105A3 true WO2000066105A3 (en) | 2001-07-19 |
WO2000066105A9 WO2000066105A9 (en) | 2001-08-09 |
Family
ID=22452594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/011584 WO2000066105A2 (en) | 1999-04-30 | 2000-04-28 | Treatment of epilepsy with imino sugars |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2000066105A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009103953A1 (en) * | 2008-02-18 | 2009-08-27 | Summit Corporation Plc | Treatment of energy utilization disease |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0350012A2 (en) * | 1988-07-08 | 1990-01-10 | Meiji Seika Kaisha Ltd. | Antiviral composition |
WO1994021230A1 (en) * | 1993-03-19 | 1994-09-29 | Cellegy Pharmaceuticals, Inc. | Method and compositions for disrupting the epithelial barrier function |
US5798366A (en) * | 1993-05-13 | 1998-08-25 | Monsanto Company | Method for treatment of CNS-involved lysosomal storage diseases |
WO2000062780A1 (en) * | 1999-04-20 | 2000-10-26 | Oxford Glycosciences (Uk) Limited | Use of glucosylceramide synthesis inhibitors in therapy |
-
2000
- 2000-04-28 WO PCT/US2000/011584 patent/WO2000066105A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0350012A2 (en) * | 1988-07-08 | 1990-01-10 | Meiji Seika Kaisha Ltd. | Antiviral composition |
WO1994021230A1 (en) * | 1993-03-19 | 1994-09-29 | Cellegy Pharmaceuticals, Inc. | Method and compositions for disrupting the epithelial barrier function |
US5798366A (en) * | 1993-05-13 | 1998-08-25 | Monsanto Company | Method for treatment of CNS-involved lysosomal storage diseases |
WO2000062780A1 (en) * | 1999-04-20 | 2000-10-26 | Oxford Glycosciences (Uk) Limited | Use of glucosylceramide synthesis inhibitors in therapy |
Non-Patent Citations (4)
Title |
---|
CLAEYSSENS, MARC ET AL: "Amine derivatives of.beta.-D-xylopyranose as reversible and irreversible inhibitors of.beta.-D-xylosidases", MECH. SACCHARIDE POLYM. DEPOLYM., [PROC. SYMP.] (1980), MEETING DATE 1978 355-69. EDITOR(S): MARSHALL, JAMES JOHN. PUBLISHER: ACADEMIC, NEW YORK, N. Y., XP000980308 * |
HELLWIG B.: "[New drugs in 1998]. NEUE ARZNEIMITTEL 1998.", DEUTSCHE APOTHEKER ZEITUNG, (17 DEC 1998) 138/51-52 SUPPL. (11-27), XP000867043 * |
P.B. GOVE: "Webster's Third New Internatinal Dictionary", 1993, MERRIAM-WEBSTER INC., SPRINGFIELD MASS., XP002158035 * |
WINCHESTER, FLEET: "Amino-sugar glycosidase inhibitors: Versatile tools for glycobiologists", GLYCOBIOLOGY, vol. 2, no. 3, June 1992 (1992-06-01), pages 199 - 210, XP000978578 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000066105A9 (en) | 2001-08-09 |
WO2000066105A2 (en) | 2000-11-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4134001A (en) | Methods for treating conditions and illnesses associated with abnormal vasculature | |
AU1271201A (en) | Azepinoindole derivatives, the production and use thereof | |
AU6540300A (en) | Display devices, accessories therefor and methods | |
AU6233200A (en) | Components and methods for use with explosives | |
AU2003271923A1 (en) | Facilitating and authenticating transactions | |
AU5279100A (en) | E1 endoglucanase variants y245g, y82r and w42r | |
AU7964200A (en) | Asymmetric organic peroxide, crosslinking agent comprising the same, and method of crosslinking with the same | |
ZA200104196B (en) | Azepinoindole derivatives, the production and use thereof. | |
IL144654A0 (en) | Pancreatic progenitor cells, methods and uses related thereto | |
AU2003215164A1 (en) | Controlled cerebrospinal infusion and shunt system | |
AU2687301A (en) | Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes | |
AU2415401A (en) | Power transistor module, power amplifier and methods in the fabrication thereof | |
WO2001028494A3 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
AU4998600A (en) | Airway-based cardiac output monitor and methods for using same | |
AU715620C (en) | Therapeutic methods and uses | |
AU6576500A (en) | Feline calicivirus genes and vaccines, in particular recombined vaccines | |
AU3425700A (en) | Non-ribosomal peptide synthetases, method for producing same and the use thereof | |
AU4996100A (en) | (s,r) formoterol methods and compositions | |
AU2003281313A1 (en) | Fiber processing agent and fiber processed with the fiber processing agent | |
AU2002363973A1 (en) | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood | |
AU2563001A (en) | Power transistor module, power amplifier and method in the fabrication thereof | |
AU2003251766A1 (en) | Partially ester-exchanged sipm and process therewith | |
AU2298200A (en) | Stabilized filler, its production and use | |
AU2003227514A1 (en) | Feed-through process and amplifier with feed-through | |
ZA200110271B (en) | Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
AK | Designated states |
Kind code of ref document: C2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: C2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
COP | Corrected version of pamphlet |
Free format text: PAGE 1/1, DRAWINGS, REPLACED BY A NEW PAGE 1/1; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09959273 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |